Arcus Biosciences (RCUS) Profit After Tax (2017 - 2025)
Historic Profit After Tax for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to -$135.0 million.
- Arcus Biosciences' Profit After Tax fell 4673.91% to -$135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$341.0 million, marking a year-over-year decrease of 2629.63%. This contributed to the annual value of -$283.0 million for FY2024, which is 781.76% up from last year.
- As of Q3 2025, Arcus Biosciences' Profit After Tax stood at -$135.0 million, which was down 4673.91% from -$112.0 million recorded in Q1 2025.
- Over the past 5 years, Arcus Biosciences' Profit After Tax peaked at $279.5 million during Q4 2021, and registered a low of -$135.0 million during Q3 2025.
- For the 5-year period, Arcus Biosciences' Profit After Tax averaged around -$58.4 million, with its median value being -$75.5 million (2021).
- Over the last 5 years, Arcus Biosciences' Profit After Tax had its largest YoY gain of 63909.71% in 2021, and its largest YoY loss of 437963.78% in 2021.
- Over the past 5 years, Arcus Biosciences' Profit After Tax (Quarter) stood at $279.5 million in 2021, then tumbled by 123.97% to -$67.0 million in 2022, then decreased by 20.9% to -$81.0 million in 2023, then dropped by 16.05% to -$94.0 million in 2024, then crashed by 43.62% to -$135.0 million in 2025.
- Its Profit After Tax was -$135.0 million in Q3 2025, compared to -$112.0 million in Q1 2025 and -$94.0 million in Q4 2024.